1. |
V3-2239 |
Needs assessment, identification of criteria and development of a model for the organization of palliative cancer care at the national level |
10/1/2022
-
9/30/2025 |
PhD Vesna Zadnik
|
1,348 |
2. |
J1-4417 |
|
10/1/2022
-
9/30/2025 |
PhD Matej Sova
|
3,691 |
3. |
J3-4504 |
|
10/1/2022
-
9/30/2025 |
PhD Metka Novak
|
1,623 |
4. |
J7-4540 |
|
10/1/2022
-
9/30/2025 |
PhD Ivica Ratoša
|
4,312 |
5. |
J7-4635 |
|
10/1/2022
-
9/30/2025 |
PhD Lucija Peterlin Mašič
|
5,617 |
6. |
L7-4491 |
|
10/1/2022
-
9/30/2025 |
PhD Igor Muševič
|
5,151 |
7. |
N1-0197 |
Improving breast cancer screening through dynamic big data analytics of Quantitative Imaging Biomarkers (QIB) |
1/1/2021
-
12/31/2024 |
PhD Robert Jeraj
|
2,559 |
8. |
V3-2236 |
Assessment of the potential impact of incineration and co-incineration of waste on human health effects: a model study on the case of the Salonit Anhovo cement plant |
10/1/2022
-
9/30/2024 |
PhD Andreja Kukec
|
8,101 |
9. |
V3-2241 |
Pilot Research on Individualized Comprehensive Rehabilitation of patients with colorectal cancer 2022-2024 |
10/1/2022
-
9/30/2024 |
PhD Nada Rotovnik Kozjek
|
3,518 |
10. |
J3-3062 |
Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer |
10/1/2021
-
9/30/2024 |
PhD Matjaž Jeras
|
2,385 |
11. |
J3-3084 |
Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy |
10/1/2021
-
9/30/2024 |
PhD Anže Smole
|
2,315 |
12. |
J2-3059 |
Online adaptive re-planning in proton and radiotherapy |
10/1/2021
-
9/30/2024 |
PhD Žiga Špiclin
|
2,023 |
13. |
J3-3083 |
Vascularization and vascular effects as predictive factors for local ablative techniques |
10/1/2021
-
9/30/2024 |
PhD Gregor Serša
|
6,313 |
14. |
L3-2622 |
Biological markers of risk for development, progression and treatment response in asbestos related diseases |
9/1/2020
-
8/31/2023 |
PhD Vita Dolžan
|
2,986 |
15. |
J3-2530 |
EFFECT OF ENDOCRINE DISRUPTORS (BISPHENOLS, PARABENS, TRICLOSAN) AND POTENTIALLY TOXIC AND ESSENTIAL CHEMICAL ELEMENTS ON THE BIRTH, INFERTILITY AND OVARIAN CANCER IN SLOVENIA |
9/1/2020
-
8/31/2023 |
PhD Irma Virant Klun
|
6,908 |
16. |
Z3-2651 |
Electrochemotherapy as in situ vaccination therapy |
9/1/2020
-
8/31/2023 |
PhD Katja Uršič Valentinuzzi
|
83 |
17. |
J3-2528 |
Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors |
9/1/2020
-
8/31/2023 |
PhD Maja Čemažar
|
2,976 |
18. |
J3-2524 |
Minimally invasive diagnostic approaches in brain tumours using circulating cell-free nucleic acids |
9/1/2020
-
8/31/2023 |
PhD Jože Pižem
|
1,722 |
19. |
J4-2546 |
Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours |
9/1/2020
-
8/31/2023 |
PhD Nataša Tozon
|
3,338 |
20. |
J3-2527 |
New approaches for prediction of cardiotoxicity in breast cancer radiotherapy |
9/1/2020
-
8/31/2023 |
PhD Tanja Marinko
|
2,187 |
21. |
J3-2537 |
New method for estimating life-years gained in population-based cancer screening programmes (S-LYG) |
9/1/2020
-
8/31/2023 |
PhD Vesna Zadnik
|
2,880 |
22. |
J3-2529 |
Role of endothelium in tumor response to radiotherapy |
9/1/2020
-
8/31/2023 |
PhD Boštjan Markelc
|
3,138 |
23. |
J7-2594 |
The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity |
9/1/2020
-
8/31/2023 |
PhD Mateja Erdani Kreft
|
4,876 |
24. |
V3-1906 |
Pilot study on individualized integrated rehabilitation of breast cancer patients 2019-2022 |
11/1/2019
-
4/30/2023 |
PhD Nikola Bešić
|
3,686 |
25. |
V3-1911 |
Slovenian genome project |
11/1/2019
-
10/31/2022 |
PhD Borut Peterlin
|
8,176 |
26. |
V3-2032 |
The impact of COVID-19 on the cancer management in Slovenia |
10/1/2020
-
9/30/2022 |
PhD Tina Žagar
|
1,912 |
27. |
Z3-1873 |
A novel vascular targeted approach based on gene therapy silencing two independent
signaling pathways in combination with radiotherapy |
7/1/2019
-
7/31/2022 |
PhD Monika Savarin
|
60 |
28. |
J2-1732 |
Computer-assisted medical image analysis for proton and radiotherapy treatment planning |
7/1/2019
-
6/30/2022 |
PhD Tomaž Vrtovec
|
1,748 |
29. |
J3-1753 |
Molecular predictors of radiation treatment response in breast cancer |
7/1/2019
-
6/30/2022 |
PhD Katja Goričar
|
1,495 |
30. |
J3-1760 |
The role of imaging and laboratory markers in the evaluation of nature and growth of thyroid nodules |
7/1/2019
-
6/30/2022 |
PhD Katja Zaletel
|
1,650 |
31. |
J5-9336 |
Opportunities and dangers of online health communities for healthcare |
7/1/2018
-
6/30/2022 |
PhD Gregor Petrič
|
1,795 |
32. |
V3-1907 |
Development of indicators and methodology for monitoring the late effects of cancer treatment in childhood at national level |
11/1/2019
-
10/31/2021 |
PhD Vesna Zadnik
|
2,085 |
33. |
Z3-1871 |
Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer |
7/1/2019
-
6/30/2021 |
PhD Maša Bošnjak
|
172 |
34. |
J3-9269 |
Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in
patients undergoing electrochemotherapy |
7/1/2018
-
6/30/2021 |
PhD Gregor Serša
|
3,238 |
35. |
J2-9225 |
Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields |
7/1/2018
-
6/30/2021 |
PhD Damijan Miklavčič
|
2,764 |
36. |
V3-1718 |
Health risk assessment for exposures of children to low-frequency electric and magnetic (EM) fields in Slovenia |
4/1/2018
-
3/31/2021 |
PhD Tadej Kotnik
|
2,431 |
37. |
N3-0059 |
Plasma-assisted wound treatment and topical introduction of molecules |
1/1/2017
-
12/31/2020 |
PhD Uroš Cvelbar
|
2,859 |
38. |
J4-8227 |
Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy
|
5/1/2017
-
4/30/2020 |
PhD Janko Kos
|
4,310 |
39. |
J1-8140 |
Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for
environmental hazard in zdravje ljudi |
5/1/2017
-
4/30/2020 |
PhD Metka Filipič
|
3,560 |
40. |
J3-8210 |
Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention |
5/1/2017
-
4/30/2020 |
PhD Mirza Šabovič
|
2,322 |
41. |
L3-8203 |
Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases |
5/1/2017
-
4/30/2020 |
PhD Vita Dolžan
|
2,756 |
42. |
J3-8202 |
Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost |
5/1/2017
-
4/30/2020 |
PhD Maja Čemažar
|
3,324 |
43. |
V3-1720 |
Analysis and estimation of requirements of human resources for cancer treatment in Slovenia |
4/1/2018
-
3/31/2020 |
PhD Branko Zakotnik
|
4,379 |
44. |
V3-1713 |
Comprehensive analysis of management of urological cancer patients with an assessment of possible delays in referrals, realization of diagnostics procedures and first treatment |
4/1/2018
-
3/31/2020 |
PhD Vesna Zadnik
|
3,772 |
45. |
Z3-8204 |
Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect |
4/1/2018
-
3/31/2020 |
PhD Tanja Jesenko
|
137 |
46. |
V3-1638 |
Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population |
10/1/2016
-
9/30/2019 |
PhD Vesna Zadnik
|
2,940 |
47. |
L2-7550 |
Elecrospun nanofibrous materials for solid state drug delivery system |
3/1/2016
-
2/28/2019 |
PhD Igor Emri
|
4,218 |
48. |
J3-7460 |
Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model |
1/1/2016
-
12/31/2018 |
PhD Primož Strojan
|
4,048 |
49. |
J3-7272 |
Methods of estimation of key indicators in population cancer survival |
1/1/2016
-
12/31/2018 |
PhD Maja Pohar Perme
|
2,876 |
50. |
J3-7372 |
Molecular biomarkers and biomarker-driven therapy in lung cancer |
1/1/2016
-
12/31/2018 |
PhD Tanja Čufer
|
4,449 |
51. |
J3-7494 |
Tunneling nanotubes for innovative urinary bladder cancer treatments |
1/1/2016
-
12/31/2018 |
PhD Mateja Erdani Kreft
|
6,728 |
52. |
J1-6730 |
Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection |
11/1/2014
-
10/31/2017 |
PhD Metka Filipič
|
3,823 |
53. |
J1-6744 |
Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis |
7/1/2014
-
6/30/2017 |
PhD Tina Kosjek
|
4,541 |
54. |
J3-6793 |
New approaches of tumor radiosenzibilization with gene therapy |
7/1/2014
-
6/30/2017 |
PhD Gregor Serša
|
4,832 |
55. |
J3-6795 |
The textural analysis of spatiotemporal changes for breast lesions diagnosis on ultrafast breast MRIs |
7/1/2014
-
6/30/2017 |
PhD Janez Žgajnar
|
1,457 |
56. |
J3-6796 |
Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin
|
7/1/2014
-
6/30/2017 |
PhD Maja Čemažar
|
4,418 |
57. |
J2-5474 |
Development of in-vivo dosimetry for applications in radiotherapy |
8/1/2013
-
7/31/2016 |
PhD Gregor Kramberger
|
3,058 |
58. |
J3-5505 |
Electrochemotherapy in treatment of deep seated tumors |
8/1/2013
-
7/31/2016 |
PhD Gregor Serša
|
4,053 |
59. |
J4-5529 |
Nitroxoline and its derivatives as new antitumour drugs |
8/1/2013
-
7/31/2016 |
PhD Janko Kos
|
5,620 |
60. |
L3-5512 |
Pilot project on acceptability and quality of HPV self sampling in non-responders to National Cervical Cancer Screening Programme NP ZORA |
8/1/2013
-
7/31/2016 |
PhD Maja Primic-Žakelj
|
4,405 |
61. |
J3-4211 |
Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems |
7/1/2011
-
6/30/2014 |
PhD Gregor Serša
|
6,157 |
62. |
J1-4044 |
Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells |
7/1/2011
-
6/30/2014 |
PhD Tom Turk
|
5,977 |
63. |
L2-4105 |
Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation |
7/1/2011
-
6/30/2014 |
PhD Damijan Miklavčič
|
4,566 |
64. |
J3-4259 |
Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters |
7/1/2011
-
6/30/2014 |
PhD Maja Čemažar
|
5,553 |
65. |
J3-4118 |
Somatic mutations in genes responsible for melanoma development and clinical disease prognosis |
7/1/2011
-
6/30/2014 |
PhD Marko Hočevar
|
2,111 |
66. |
J1-4131 |
Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors |
7/1/2011
-
6/30/2014 |
PhD Iztok Turel
|
5,596 |
67. |
J3-4195 |
USTVARJANJE LINIJE MULTIPOTENTNIH / PLURIPOTENTNIH MATIČNIH CELIC IZ ODRASLEGA HUMANEGA TKIVA JAJČNIKA IN MOD: PERSPEKTIVA ZA REPRODUKTIVNO IN REGENERATIVNO MEDICINO. (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Irma Virant Klun
|
3,367 |
68. |
J2-3639 |
New lipid model systems for determination of electroporation basic mechanisms |
5/1/2010
-
4/30/2013 |
PhD Damijan Miklavčič
|
4,847 |
69. |
V3-1049 |
Študija celostnega sklapljanja zdravstvenih in okoljskih podatkov v Zasavju kot model študije za podporo pri oblikovanju in izvajanju medsektorskih politik s področja okolja in zdravja (Slovene) |
10/1/2010
-
9/30/2012 |
PhD Jerneja Farkaš-Lainščak
|
4,096 |
70. |
J3-2359 |
Genetska in terapevtska raznolikost bolnikov pri načrtovanju individualizirane terapije pljučnega raka (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Mitja Košnik
|
4,064 |
71. |
J3-2277 |
Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Maja Čemažar
|
2,684 |
72. |
L3-2371 |
Ocena preživetja bolnic z napredovalim karcinomom jajčnikov glede na primarno oziroma laparoskopsko ocenjeno optimalno citoredukcijo (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Borut Kobal
|
1,966 |
73. |
J3-2069 |
Uporaba magnetne nanotehnologije za transfekcijo normalnih in tumorskih celic (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Gregor Serša
|
2,678 |
74. |
V3-1048 |
Izdelava strokovnih podlag za zbiranje in spremljanje izbranih kazalnikov učinkovitosti Državnega programa obvladovanja raka (Slovene) |
10/1/2010
-
3/31/2012 |
PhD Maja Primic-Žakelj
|
5,119 |
75. |
J3-0485 |
Antiangiogenic siRNA for the treatment of advanced malignant melanoma |
2/1/2008
-
1/30/2011 |
PhD Maja Čemažar
|
2,453 |
76. |
L3-0113 |
Development and validation of clinical tools developed on International Classification of Functioning, Health and Disability (ICF) |
2/1/2008
-
1/30/2011 |
PhD Helena Burger
|
3,058 |
77. |
J3-0465 |
Editing of immunosurviellance with the whole cell tumor vaccines and CpG ODN |
2/1/2008
-
1/30/2011 |
PhD Srdjan Novaković
|
1,620 |
78. |
J3-0570 |
Genetic and radioisotopic methods in diagnostics and therapy of thyroid carcinoma |
2/1/2008
-
1/30/2011 |
PhD Nikola Bešić
|
1,863 |
79. |
L3-0431 |
Genetics of breast cancer and hormone replacement therapy |
2/1/2008
-
1/30/2011 |
PhD Ksenija Geršak
|
3,627 |
80. |
J3-0480 |
Genetics of hereditary melanoma |
2/1/2008
-
1/30/2011 |
PhD Marko Hočevar
|
1,463 |
81. |
L3-0494 |
Method for multimodal comparative analysis of 3D volumes, based on CT/MR images |
2/1/2008
-
1/30/2011 |
PhD Robert Hudej
|
278 |
82. |
L3-0449 |
New approaches in the treatment of lung cancer II. |
2/1/2008
-
1/30/2011 |
PhD Matjaž Zwitter
|
1,888 |
83. |
J1-0200 |
Synthesis of novel ruthenium compounds and their potential use in electrochemotherapy of tumors |
2/1/2008
-
1/30/2011 |
PhD Iztok Turel
|
4,175 |
84. |
J3-0124 |
The role of recombinant human erythropoietin on gene expression and signal transduction in breast cancer |
2/1/2008
-
1/30/2011 |
PhD Nataša Debeljak
|
3,656 |
85. |
J3-0020 |
Three-dimensional analysis of the face among Slovenian children in the period of growth and development |
2/1/2008
-
1/30/2011 |
PhD Maja Ovsenik
|
1,144 |
86. |
L3-9346 |
Analysis of late effects after treatment of cancer in children and young adults |
7/1/2007
-
6/30/2010 |
PhD Berta Jereb
|
2,581 |
87. |
J3-9580 |
Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens |
1/1/2007
-
12/31/2009 |
PhD Gregor Serša
|
2,328 |
88. |
J3-9161 |
Fertility after testicular cancer treatment |
1/1/2007
-
12/31/2009 |
PhD Branko Zorn
|
3,559 |
89. |
L2-9212 |
Verification of radioactive sources positioning during brachytherapy |
1/1/2007
-
12/31/2009 |
PhD Gregor Kramberger
|
2,157 |
90. |
M1-0153 |
Biološka dozimetrija na osnovi magnetno resonančnih metod (Slovene) |
6/1/2006
-
11/30/2008 |
PhD Marjeta Šentjurc
|
6,696 |
91. |
V3-0371 |
Znanstveno raziskovalni zavodi na področju biomedicinskih znanosti - izsledki biomedicinskih raziskav in učinkovita oblika organiziranosti (Slovene) |
10/1/2006
-
9/30/2008 |
PhD Bojan Zalar
|
4,944 |
92. |
J3-7488 |
Hereditary breast and ovarian cancer in Slovenia |
9/1/2005
-
8/31/2008 |
PhD Janez Žgajnar
|
3,459 |
93. |
J3-7044 |
Treatment of malignant tumours with electrogene therapy |
9/1/2005
-
8/31/2008 |
PhD Maja Čemažar
|
3,219 |
94. |
J3-6083 |
Dedni melanom pri Slovencih (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Marko Hočevar
|
2,090 |
95. |
J3-6092 |
Genetske in radioizotopne metode v diagnostiki in terapiji raka ščitnice (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Nikola Bešić
|
2,000 |
96. |
J3-6389 |
Kirurgija raka prebavil (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Stanislav Repše
|
2,886 |
97. |
J3-6044 |
Nove poti zdravljenja pljučnega raka (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Matjaž Zwitter
|
2,643 |
98. |
L3-6068 |
Primerjava potekov bolezni bolnic z mikrometastazo v prvi bezgavki, ki so prestale disekcijo pazduhe, s poteki onih, ki so bile zgolj opazovane (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Jurij Lindtner
|
1,960 |
99. |
J3-6363 |
Priprava tumorskih vakcin: hibridomi in gensko spremenjene vakcine (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Srdjan Novaković
|
2,388 |
100. |
J3-6063 |
Rak materničnega vratu pri ženskah z rednimi ginekološkimi pregledi - zagotavljanje in nadziranje kakovosti presejanja (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Marjetka Uršič Vrščaj
|
1,593 |
101. |
L3-6039 |
Kasne posledice zdravljenja raka pri otrocih in mladih odraslih (Slovene) |
2/1/2004
-
1/30/2007 |
PhD Berta Jereb
|
2,908 |
102. |
L3-6059 |
Prospektivna randomizirana klinična raziskava faze ll: 5-FU/LV in Irinotekan v primerjavi s kombinacijo Kapecitabin in Irinotekan v prvem zdravljenju metastatske bolezni pri bolnikih s karcinomom debelega črevesa in danke (Slovene) |
2/1/2004
-
1/30/2007 |
PhD Janja Ocvirk
|
1,722 |
103. |
J3-6260 |
Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene) |
2/1/2004
-
1/30/2007 |
PhD Marija Auersperg
|
4,151 |
104. |
Z3-6144 |
Raziskava možnosti uporabe parafina za filtrski kompenzator v megavoltni radioterapiji (Slovene) |
2/1/2004
-
1/30/2006 |
PhD Primož Strojan
|
827 |
105. |
L3-5074 |
EARLY DETECTION OF LUNG CANCER AND RISK FACTORS FOR DEVELOPMENT AND PROGRESS OF DISEASE |
1/1/2003
-
12/31/2005 |
PhD Marjeta Terčelj Zorman
|
2,371 |
106. |
L3-5234 |
Genotoxic and late effect of treatment on somatic cells of patients with testicular tumor |
1/1/2003
-
12/31/2005 |
PhD Cvetka Bilban-Jakopin
|
829 |
107. |
J3-5296 |
Model of artificial neural networks (ANN) - help for clinicians in selecting adjuvant treatment in breast cancer patients |
1/1/2003
-
12/31/2005 |
PhD Branko Zakotnik
|
987 |
108. |
L3-5012 |
MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS |
1/1/2003
-
12/31/2005 |
PhD Metka Ravnik-Glavač
|
4,468 |
109. |
J3-5299 |
Vpliv novih metod patologije in klinike na rezultate zdravljenja bolnikov s tumorji EWing/PNET (Slovene) |
1/1/2003
-
12/31/2005 |
PhD Živa Pohar Marinšek
|
1,785 |
110. |
J3-5325 |
Kasne posledice na ledvicah po zdravljenju raka pri otrocih (Slovene) |
1/1/2003
-
6/30/2005 |
PhD Radoslav Kveder
|
2,894 |
111. |
J3-4203 |
Adjuvantno zdravljenje bolnikov z malignim melanomom stadij llB,C z interferonom alfa-2A (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Zvonimir Rudolf
|
4,268 |
112. |
J3-4308 |
Napovedni pomen katepsinov in stefinov pri napredovalnem karcinomu glave in vratu zdravljenem s konkomitantno radiokemoterapijo (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Alojz Šmid
|
2,014 |
113. |
J3-4291 |
Napovedni pomen proteinov uPA sistema za odgovor na sistemsko zdravljenje in za lokalno ponovitev bolezni pri bolnicah z rakom dojk (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Tanja Čufer
|
4,313 |
114. |
J3-4207 |
Ocena učinkovitosti presejanja za raka materničnega vratu v Sloveniji; študija primerov s kontrolami (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Maja Primic-Žakelj
|
3,069 |
115. |
J3-4178 |
Pomen okultnih metastaz v pazdušnih bezgavkah pri zgodnjem karcinomu dojke (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Matej Bračko
|
2,015 |
116. |
L3-4278 |
Po odstranitvi varovalne bezgavke: Obsevanje ali kirurgija (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Marko Snoj
|
1,787 |
117. |
J3-4176 |
Predklinične raziskave elektrogenske terapije v onkologiji (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Maja Čemažar
|
4,662 |
118. |
J3-3501 |
Creation of tumor vaccines |
7/1/2001
-
6/30/2004 |
PhD Srdjan Novaković
|
3,361 |
119. |
J3-3104 |
Diagnostics and therapy of the nonpalpable breast cancer |
7/1/2001
-
6/30/2004 |
PhD Jurij Lindtner
|
1,502 |
120. |
J3-3495 |
Flow Cytometric Immunophenotyping in Diagnosis, Prognosis and Treatment of non-Hodgkin's Lymphomas |
7/1/2001
-
6/30/2004 |
PhD Veronika Kloboves-Prevodnik
|
1,241 |
121. |
J3-3460 |
Genetic and radioisotopic methods in diagnosis and therapy of thyroid carcinoma |
7/1/2001
-
6/30/2004 |
PhD Nikola Bešić
|
1,800 |
122. |
J3-3395 |
Genetic causes of female infertility 2
|
7/1/2001
-
6/30/2004 |
PhD Ksenija Geršak
|
4,483 |
123. |
J3-3010 |
Inoperable carcinoma of the head and neck: an attempt to improve treatment results and analysis of some biological characteristics |
7/1/2001
-
6/30/2004 |
PhD Primož Strojan
|
2,548 |
124. |
L3-3375 |
Introduction of threedimensional radiotherapy treatment planning in Slovenia |
7/1/2001
-
6/30/2004 |
PhD Hotimir Lešničar
|
5,606 |
125. |
J3-3076 |
Lipid peroxidation and functional damage in target tissues and organs in citizens of Idrija and mercury miners exposed to the elemental mercury |
7/1/2001
-
6/30/2004 |
PhD Joško Osredkar
|
6,001 |
126. |
J3-3021 |
Multimodality treatment for lung cancer |
7/1/2001
-
6/30/2004 |
PhD Matjaž Zwitter
|
1,756 |
127. |
J3-3489 |
New biomedical applications of electroporation |
7/1/2001
-
6/30/2004 |
PhD Gregor Serša
|
3,892 |
128. |
J3-3497 |
Phyllodes tumor of the breast. Histological, cytological, immunohistochemical and nuclear texture features in prediction of its biological behavior |
7/1/2001
-
6/30/2004 |
PhD Janez Lamovec
|
1,435 |
129. |
J3-3101 |
Quantitative image analysis of non-small cell lung cancer: estimation of biological potential and treatment planning based on DNA ploidy and nuclear texture features |
7/1/2001
-
6/30/2004 |
PhD Margareta Strojan Fležar
|
2,021 |
130. |
J3-3026 |
Role of cytomorphology, DNA measurements, Ki 67 and apoptosis for planning and predicting the effect of chemotherapy in thyroid cancer |
7/1/2001
-
6/30/2004 |
PhD Ana Pogačnik
|
3,300 |
131. |
J3-3464 |
Role of tyrosinase RT-PCR in staging of patients with malignant melanoma |
7/1/2001
-
6/30/2004 |
PhD Marko Hočevar
|
2,699 |
132. |
J3-3303 |
Surgery for gastrointestinal cancer |
7/1/2001
-
6/30/2004 |
PhD Stanislav Repše
|
2,611 |
133. |
J3-3506 |
The Role of High risk Human Papilloma Viruses in the Detection of Cervical Cancer
|
7/1/2001
-
6/30/2004 |
PhD Marjetka Uršič Vrščaj
|
1,913 |
134. |
J3-2450 |
Biološke značilnosti raka glave in vratu in uspeh zdravljenja (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Alojz Šmid
|
1,731 |
135. |
J3-2411 |
Histološki in imunohistokemični napovedi dejavniki pri karcinomu dojke v stadiju I (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Matej Bračko
|
2,353 |
136. |
J3-2165 |
Napovedni pomen proteinov uPA sistema in katepsinov za prezivetje in odgovor na sistemsko zdravljenje bolnic z rakom dojk (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Tanja Čufer
|
4,373 |
137. |
L3-2061 |
Psihosocialni vplivi raka dojke na druzinsko zivljenje (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Maja Primic-Žakelj
|
1,131 |
138. |
J3-2049 |
Uporaba elektroporacij v genski terapiji (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Maja Čemažar
|
3,954 |
139. |
L3-2161 |
Varovalna bezgavka (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Marko Snoj
|
1,399 |
140. |
L3-1259 |
Modulacija imunskega odziva pri bolnikih z malignim melanomom rezistentnim na kemoterapijo (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Borut Štabuc
|
2,736 |
141. |
J3-1220 |
Napovedna vrednost oksigeniranosti tumorjev pri izbranih bolnikih z malignomom glave in vratu (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Hotimir Lešničar
|
2,506 |
142. |
L3-1192 |
PovejMi: telemedicinska pomoč bolnicam z rakom dojke (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Ankica Babič
|
3,716 |
143. |
L3-1008 |
Razpoznavanje pljučnih okužb pri jatrogeno imunosuprimiranih bolnikih (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Aleksandra Skralovnik-Štern
|
1,441 |
144. |
J3-0428 |
Genetski dejavniki pri ženski neplodnosti (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Ksenija Geršak
|
2,411 |
145. |
J3-0097 |
Okužbe z virusi papiloma pri intraepitelijskem raku materničnega vratu (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Marjetka Uršič Vrščaj
|
1,442 |
146. |
J3-0123 |
Protitelesa proti proteinu p53 in p53 v serumu bolnikov z malignimi tumorji (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Zvonimir Rudolf
|
3,464 |
147. |
J3-0143 |
Raziskave zdravljenja pljučnega raka: etična in klinična razpotja (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Matjaž Zwitter
|
732 |
148. |
J1-0640 |
Serumske vrednosti cisteinskih proteinaz katepsinov B, H in L in njihovih inhibitorjev stefinov in cistatinov kot pokazateljev diagnoze (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Janko Kos
|
2,233 |
149. |
J3-0146 |
Zdravljenje malignih solidnih tumorjev z interferonom alfa (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Borut Štabuc
|
2,257 |
150. |
J3-8752 |
Napoved incidence raka v Sloveniji do leta 2000 in 2010 (Slovene) |
1/1/1997
-
6/30/2001 |
PhD Vera Pompe-Kirn
|
1,382 |
151. |
J3-7843 |
Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Gregor Serša
|
3,984 |
152. |
J3-7919 |
Genetska analiza nekaterih tumor supresor genov (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Metka Ravnik-Glavač
|
1,344 |
153. |
J3-7841 |
Kirurgija raka prebavil - primerjava želodčnega in kolorektalnega raka (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Stanislav Repše
|
1,171 |
154. |
J3-7953 |
Konvencionalne in moderne kvantitativne metode pri oceni progresije sarkomov mehkih tkiv (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Rastko Golouh
|
2,419 |
155. |
J3-7952 |
Poskus izboljšanja zdravljenja malignih tumorjev, zmanjšanja posledic zdravljenja in proučevanje prognostičnih dejavnikov (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Marjan Budihna
|
2,070 |
156. |
J3-7842 |
Racionalna diagnostika in zdravljenje tumorjev ščitnice (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Nikola Bešić
|
2,880 |
157. |
J3-7878 |
Razvoj avtolognih tumorskih vakcin (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Srdjan Novaković
|
5,414 |
158. |
J1-7428 |
Regulation of gene expression by steroids in primitive eucaryots and the application of P450 gene technology in medicine |
1/1/1996
-
6/30/2001 |
PhD Katja Breskvar
|
1,513 |
159. |
J3-7956 |
Slikovna citomerija pri detekciji, prognozi in zdravljenju malignih tumorjev (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Veronika Kloboves-Prevodnik
|
3,025 |
160. |
L3-0362 |
Causes of constant inicidence of invasive cervical cancer in Slovenia |
7/1/1998
-
6/30/2000 |
PhD Stelio Rakar
|
1,831 |
161. |
L1-0469 |
Optimization of MDP and TNF analogues having therapeutic potential |
7/1/1998
-
6/30/2000 |
PhD Anton Štalc
|
6,026 |
162. |
L3-9202 |
Adjuvant systemic therapy in operable breast cancer patients |
11/1/1998
-
12/31/1999 |
PhD Jurij Lindtner
|
162 |
163. |
J3-8924 |
Analysis of late sequelae of cancer treatment in childhood |
1/1/1997
-
12/31/1999 |
PhD Berta Jereb
|
460 |
164. |
J3-8679 |
Apoptosis and the immune system |
1/1/1997
-
12/31/1999 |
PhD Vladimir Kotnik
|
6,334 |
165. |
J3-8743 |
Biological characteristics of head and neck cancer and the results of treatment |
1/1/1997
-
12/31/1999 |
PhD Alojz Šmid
|
1,100 |
166. |
J3-8748 |
Boron Neutron Capture Therapy - Employment of drug delivery systems for increased antitumor effectiveness |
1/1/1997
-
12/31/1999 |
PhD Janez Škrk
|
4,772 |
167. |
J3-8744 |
Phospholipase a2 in tumor tissue |
1/1/1997
-
12/31/1999 |
PhD Marko Snoj
|
1,113 |
168. |
J3-8746 |
Prognostic value of uPA, PAI 1 and PAI 2 in solid tumors |
1/1/1997
-
12/31/1999 |
PhD Tanja Čufer
|
3,894 |
169. |
L3-8919 |
Proteaze in proteazni inhibitorji v napredovanju raka: možna uporaba v prognozi, preventivi in antimetastatski terapiji (Slovene) |
1/1/1997
-
12/31/1999 |
PhD Tamara Lah Turnšek
|
3,598 |
170. |
L3-8847 |
Pozitronska emisijska tomografija (Slovene) |
7/1/1997
-
6/30/1999 |
PhD Nataša Budihna
|
1,457 |
171. |
J3-8922 |
Metastaze pri hitro rastočih tumorjih (Slovene) |
1/1/1997
-
12/31/1998 |
|
24 |
172. |
L1-8877 |
Razvoj polvodniških detektorjev za rentgensko slikanje (Slovene) |
1/1/1997
-
12/31/1998 |
PhD Vladimir Cindro
|
1,748 |
173. |
L3-8755 |
Uvedba stereotaktične radiokirurgije z lin. pospeševalnikom v Sloveniji (Slovene) |
1/1/1997
-
12/31/1998 |
PhD Marjan Budihna
|
293 |
174. |
L3-8754 |
Dodatno sistemsko zdravljenje bolnic z rakom dojk stadijev I in II (Slovene) |
1/1/1997
-
10/31/1998 |
PhD Jurij Lindtner
|
1,562 |
175. |
L1-7379 |
Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene) |
1/1/1996
-
6/30/1998 |
PhD Anton Štalc
|
5,854 |